Form 4: Recursion Pharmaceuticals Director Bumpus Receives Stock and Option Grants

Director Namandje Bumpus receives stock and option grants from Recursion Pharmaceuticals under the company's Outside Director Compensation Policy.

Summary

• Namandje Bumpus, a director at Recursion Pharmaceuticals, received a grant of 36,549 shares of Class A Common Stock and an option to purchase 73,099 shares of Class A Common Stock on March 17, 2025.
• These grants were automatically awarded under Recursion's Outside Director Compensation Policy.
• The restricted stock units and options vest in three equal installments on the first three anniversaries of March 17, 2025, contingent upon continued service as a provider.
• The exercise price for the stock options is $6.84.
• Following the transaction, Bumpus directly owns 36,549 shares of Class A Common Stock and options for 73,099 shares.

Sentiment

Score: 7

Explanation: The document reflects a routine director compensation event, which is generally viewed neutrally to positively as it aligns director interests with shareholders. The sentiment is moderately positive due to the incentive structure.

Positives

• The grant of stock and options aligns the director's interests with those of the shareholders.
• The vesting schedule encourages continued service and commitment to the company.

Future Outlook

The vesting of the stock and options is contingent upon the director's continued service with the company.

Industry Context

Granting stock options and restricted stock units to directors is a common practice in the pharmaceutical industry to incentivize and retain talent.

Comparison to Industry Standards

• Director compensation packages, including stock options and restricted stock units, are standard practice among publicly traded biotechnology companies such as Amgen, Biogen, and Gilead Sciences.
• The vesting schedules, typically over a three-year period, are also consistent with industry norms to ensure long-term alignment with company performance.

Stakeholder Impact

• Shareholders: Aligns director's interests with shareholder value through equity ownership.
• Director: Provides incentive and reward for service on the board.

Key Dates

Keywords

Recursion Pharmaceuticals, Director Compensation, Stock Options, Restricted Stock Units, Form 4, RXRX, Insider Transaction